Advertisement
Screener

TRACON Pharmaceuticals, Inc. Patents: Active

TRACON Pharmaceuticals, Inc. Active Patents

3 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2016-10-28: Application 15337113; Invention Endoglin Antibodies; Applicant Tracon Pharmaceuticals, Inc.; Status Patented Case.
  • 2015-02-11: Application 14421108; Invention Antibody Formulations and Uses Thereof; Applicant Tracon Pharmaceuticals, Inc.; Status Patented Case.
  • 2013-10-15: Application 14054446; Invention ENDOGLIN ANTIBODIES; Applicant TRACON PHARMACEUTICALS, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2016-10-2815337113Endoglin AntibodiesTracon Pharmaceuticals, Inc.Patented Case2018-04-179944714US20170044267A1
Charles Theuer
Maximiliano Vasquez
United States
United States
NATARAJAN, MEERA
2015-02-1114421108Antibody Formulations and Uses ThereofTracon Pharmaceuticals, Inc.Patented Case2019-02-0510195281US20150209430A1
Suzanne Benedict
Mark Cornell Manning
Brian M. Murphy
Sharon Real
Charles Theuer
United States
United States
United States
United States
United States
KIM, YUNSOO
2013-10-1514054446ENDOGLIN ANTIBODIESTRACON PHARMACEUTICALS, INC.Patented Case2015-10-069150652US20140314742A1
Charles Theuer
Maximiliano Vasquez
United States
United States
NATARAJAN, MEERA